• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于传感器的早期帕金森病监测平台。

A Sensor-Based Platform for Early-Stage Parkinson's Disease Monitoring.

机构信息

Bioinformatics and Human Electrophysiology Laboratory, Department of Informatics, Ionian University, Corfu, Greece.

Telesto Technologies, Athens, Greece.

出版信息

Adv Exp Med Biol. 2023;1424:23-29. doi: 10.1007/978-3-031-31982-2_2.

DOI:10.1007/978-3-031-31982-2_2
PMID:37486475
Abstract

Biosensing platforms have gained much attention in clinical practice screening thousands of samples simultaneously for the accurate detection of important markers in various diseases for diagnostic and prognostic purposes. Herein, a framework for the design of an innovative methodological approach combined with data processing and appropriate software in order to implement a complete diagnostic system for Parkinson's disease exploitation is presented. The integrated platform consists of biochemical and peripheral sensor platforms for measuring biological and biometric parameters of examinees, a central collection and management unit along with a server for storing data, and a decision support system for patient's state assessment regarding the occurrence of the disease. The suggested perspective is oriented on data processing and experimental implementation and can provide a powerful holistic evaluation of personalized monitoring of patients or individuals at high risk of manifestation of the disease.

摘要

生物传感平台在临床实践中受到了广泛关注,可同时对数千个样本进行分析,以准确检测各种疾病中的重要标志物,从而达到诊断和预后的目的。本文提出了一种创新方法结合数据处理和适当软件的设计框架,以实现帕金森病诊断系统的开发。该集成平台包括生化和外周传感器平台,用于测量受检者的生物和生物计量参数,以及一个中央收集和管理单元以及一个用于存储数据的服务器,以及一个用于评估患者疾病发生状态的决策支持系统。本研究提出的方法侧重于数据处理和实验实现,可为患者或有疾病表现高风险的个体的个性化监测提供强大的整体评估。

相似文献

1
A Sensor-Based Platform for Early-Stage Parkinson's Disease Monitoring.基于传感器的早期帕金森病监测平台。
Adv Exp Med Biol. 2023;1424:23-29. doi: 10.1007/978-3-031-31982-2_2.
2
A Sensor-Based Perspective in Early-Stage Parkinson's Disease: Current State and the Need for Machine Learning Processes.基于传感器的早期帕金森病视角:现状与机器学习过程的需求。
Sensors (Basel). 2022 Jan 6;22(2):409. doi: 10.3390/s22020409.
3
Wearable sensor use for assessing standing balance and walking stability in people with Parkinson's disease: a systematic review.可穿戴传感器用于评估帕金森病患者的站立平衡和行走稳定性:一项系统综述。
PLoS One. 2015 Apr 20;10(4):e0123705. doi: 10.1371/journal.pone.0123705. eCollection 2015.
4
Predictive Big Data Analytics: A Study of Parkinson's Disease Using Large, Complex, Heterogeneous, Incongruent, Multi-Source and Incomplete Observations.预测性大数据分析:一项使用大规模、复杂、异构、不一致、多源和不完整观测数据对帕金森病的研究。
PLoS One. 2016 Aug 5;11(8):e0157077. doi: 10.1371/journal.pone.0157077. eCollection 2016.
5
Telemonitoring of patients with Parkinson's disease using inertia sensors.使用惯性传感器对帕金森病患者进行远程监测。
Appl Clin Inform. 2014 May 28;5(2):503-11. doi: 10.4338/ACI-2014-04-RA-0046. eCollection 2014.
6
Combined Vision and Wearable Sensors-based System for Movement Analysis in Rehabilitation.基于视觉与可穿戴传感器的康复运动分析系统
Methods Inf Med. 2017 Mar 23;56(2):95-111. doi: 10.3414/ME16-02-0013. Epub 2016 Dec 6.
7
An Integrated Multi-Sensor Approach for the Remote Monitoring of Parkinson's Disease.一种用于帕金森病远程监测的集成多传感器方法。
Sensors (Basel). 2019 Nov 2;19(21):4764. doi: 10.3390/s19214764.
8
[Wearable Devices for Movement Monitoring of Patients with Parkinson’s Disease].用于帕金森病患者运动监测的可穿戴设备
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2016 Dec;33(6):1183-90.
9
Accurate Monitoring of Parkinson's Disease Symptoms With a Wearable Device During COVID-19 Pandemic.在 COVID-19 大流行期间,使用可穿戴设备准确监测帕金森病症状。
In Vivo. 2021 Jul-Aug;35(4):2327-2330. doi: 10.21873/invivo.12507.
10
Home monitoring of patients with Parkinson's disease via wearable technology and a web-based application.通过可穿戴技术和基于网络的应用程序对帕金森病患者进行家庭监测。
Annu Int Conf IEEE Eng Med Biol Soc. 2010;2010:4411-4. doi: 10.1109/IEMBS.2010.5627124.

本文引用的文献

1
A Sensor-Based Perspective in Early-Stage Parkinson's Disease: Current State and the Need for Machine Learning Processes.基于传感器的早期帕金森病视角:现状与机器学习过程的需求。
Sensors (Basel). 2022 Jan 6;22(2):409. doi: 10.3390/s22020409.
2
The Parkinson's progression markers initiative (PPMI) - establishing a PD biomarker cohort.帕金森病进展标志物计划(PPMI)——建立帕金森病生物标志物队列。
Ann Clin Transl Neurol. 2018 Oct 31;5(12):1460-1477. doi: 10.1002/acn3.644. eCollection 2018 Dec.
3
Recent Advances in Biomarkers for Parkinson's Disease.
帕金森病生物标志物的最新进展
Front Aging Neurosci. 2018 Oct 11;10:305. doi: 10.3389/fnagi.2018.00305. eCollection 2018.
4
Diagnostic biomarkers for Parkinson's disease at a glance: where are we?帕金森病的诊断生物标志物一览:我们在哪里?
J Neural Transm (Vienna). 2018 Oct;125(10):1417-1432. doi: 10.1007/s00702-018-1910-4. Epub 2018 Aug 25.
5
The Incidence of Parkinson's Disease: A Systematic Review and Meta-Analysis.帕金森病的发病率:一项系统评价与荟萃分析
Neuroepidemiology. 2016;46(4):292-300. doi: 10.1159/000445751. Epub 2016 Apr 23.
6
Parkinson's disease.帕金森病。
Lancet. 2015 Aug 29;386(9996):896-912. doi: 10.1016/S0140-6736(14)61393-3. Epub 2015 Apr 19.
7
Structural insights into amyloid oligomers of the Parkinson disease-related protein α-synuclein.帕金森病相关蛋白α-突触核蛋白淀粉样寡聚体的结构见解
J Biol Chem. 2014 Sep 26;289(39):26733-26742. doi: 10.1074/jbc.M114.566695. Epub 2014 Aug 20.
8
CSF levels of DJ-1 and tau distinguish MSA patients from PD patients and controls.脑脊液中 DJ-1 和 tau 水平可将 MSA 患者与 PD 患者和对照组区分开来。
Parkinsonism Relat Disord. 2014 Jan;20(1):112-5. doi: 10.1016/j.parkreldis.2013.09.003. Epub 2013 Sep 12.
9
The Unified Parkinson's Disease Rating Scale as a predictor of peak aerobic capacity and ambulatory function.统一帕金森病评定量表作为峰值有氧运动能力和步行功能的预测指标。
J Rehabil Res Dev. 2012;49(8):1269-76. doi: 10.1682/jrrd.2011.06.0103.
10
CSF Aβ(42) and tau in Parkinson's disease with cognitive impairment.帕金森病伴认知障碍患者的脑脊液 Aβ(42)和 tau。
Mov Disord. 2010 Nov 15;25(15):2682-5. doi: 10.1002/mds.23287.